TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer

被引：0

作者：

Florent Dufour

Linda Silina

Hélène Neyret-Kahn

Aura Moreno-Vega

Clémentine Krucker

Narjesse Karboul

Marion Dorland-Galliot

Pascale Maillé

Elodie Chapeaublanc

Yves Allory

Nicolas Stransky

Hélène Haegel

Thierry Menguy

Vanessa Duong

François Radvanyi

Isabelle Bernard-Pierrot

机构：

[1] PSL Research University,Institut Curie

[2] CNRS,undefined

[3] UMR144,undefined

[4] Equipe Labellisée Ligue contre le Cancer,undefined

[5] Sorbonne Universités,undefined

[6] UPMC Université Paris 06,undefined

[7] AP-HP,undefined

[8] Henri-Mondor Hospital,undefined

[9] Department of Pathology,undefined

[10] Institut Curie,undefined

[11] Department of Pathology,undefined

[12] ELSALYS BIOTECH SAS,undefined

来源：

British Journal of Cancer | 2019年 / 120卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：555 / 564

页数：9

共 55 条

[31] Schroeder GM(2014)TYRO3 as a potential therapeutic target in breast cancer Anticancer Res. 34 112-undefined
[32] Earl J(2017)TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy Immunol. Rev. 276 undefined-undefined
[33] Giacinti C(2017)Phosphatidylserine sensing by TAM receptors regulates AKT-dependent chemoresistance and PD-L1 expression Mol. Cancer Res. 15 undefined-undefined
[34] Giordano A(2016)Rationale for anti-CD137 cancer immunotherapy Eur. J. Cancer 54 undefined-undefined
[35] Chen X(undefined)undefined undefined undefined undefined-undefined
[36] Duan N(undefined)undefined undefined undefined undefined-undefined
[37] Zhang C(undefined)undefined undefined undefined undefined-undefined
[38] Zhang W(undefined)undefined undefined undefined undefined-undefined
[39] Schmitz R(undefined)undefined undefined undefined undefined-undefined
[40] Avilla E(undefined)undefined undefined undefined undefined-undefined